Bone Biologics Corporation (BBLG)

NASDAQ: BBLG · IEX Real-Time Price · USD

1.110

0.00 (0.00%)

At close: Jul 19, 2024, 4:00 PM

1.130

+0.020 (1.80%)

Pre-market: Jul 22, 2024, 9:01 AM EDT

Bone Biologics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2007
Net Income	-6.1	-8.95	-1.48	-1.61	-1.82	-3.42	Upgrade
Depreciation & Amortization	0	0	0	0	0	0	Upgrade
Share-Based Compensation	0.16	0.15	0.27	0.21	0	0.15	Upgrade
Other Operating Activities	-3.57	-0.76	-2.35	0.18	1.4	0.02	Upgrade
Operating Cash Flow	-9.51	-9.56	-3.57	-1.23	-0.43	-3.25	Upgrade
Share Issuance / Repurchase	2.1	5.04	4.43	6.86	0	0	Upgrade
Debt Issued / Paid	0	0	0	1.05	0.4	2.32	Upgrade
Financing Cash Flow	2.1	5.04	4.43	7.9	0.4	2.32	Upgrade
Net Cash Flow	-2.96	-4.51	0.86	6.68	-0.02	-0.93	Upgrade
Free Cash Flow	-9.51	-9.56	-3.57	-1.23	-0.43	-3.25	Upgrade
Free Cash Flow Per Share	-14.39	-36.31	-74.84	-64.92	-35.20	-267.57	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).